199 related articles for article (PubMed ID: 35039052)
1. The SF3B1
Guo J; Li C; Fang Q; Liu Y; Wang D; Chen Y; Xie W; Zhang Y
J Exp Clin Cancer Res; 2022 Jan; 41(1):26. PubMed ID: 35039052
[TBL] [Abstract][Full Text] [Related]
2. Somatic SF3B1 hotspot mutation in prolactinomas.
Li C; Xie W; Rosenblum JS; Zhou J; Guo J; Miao Y; Shen Y; Wang H; Gong L; Li M; Zhao S; Cheng S; Zhu H; Jiang T; Ling S; Wang F; Zhang H; Zhang M; Qu Y; Zhang Q; Li G; Wang J; Ma J; Zhuang Z; Zhang Y
Nat Commun; 2020 May; 11(1):2506. PubMed ID: 32427851
[TBL] [Abstract][Full Text] [Related]
3. Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis.
Liu B; Liu Z; Chen S; Ki M; Erickson C; Reis-Filho JS; Durham BH; Chang Q; de Stanchina E; Sun Y; Rabadan R; Abdel-Wahab O; Chandarlapaty S
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33031100
[TBL] [Abstract][Full Text] [Related]
4. SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances.
Fuentes-Fayos AC; Pérez-Gómez JM; G-García ME; Jiménez-Vacas JM; Blanco-Acevedo C; Sánchez-Sánchez R; Solivera J; Breunig JJ; Gahete MD; Castaño JP; Luque RM
J Exp Clin Cancer Res; 2022 Jan; 41(1):39. PubMed ID: 35086552
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
[TBL] [Abstract][Full Text] [Related]
6. Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.
Liberante FG; Lappin K; Barros EM; Vohhodina J; Grebien F; Savage KI; Mills KI
Sci Rep; 2019 Feb; 9(1):2678. PubMed ID: 30804405
[TBL] [Abstract][Full Text] [Related]
7. [Screening of drugs that selectively inhibit uveal melanoma cells with SF3B1 mutations].
Luo X; Ren C; Liu X; Zhang G; Huang S; Yu L; Li Y
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1835-1842. PubMed ID: 35012916
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation.
Li Z; Zhao B; Shi Y; Liang Y; Qian R; Wan Y
J Biochem; 2021 Sep; 170(1):69-77. PubMed ID: 33751071
[TBL] [Abstract][Full Text] [Related]
9. SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis.
Yang JY; Huo YM; Yang MW; Shen Y; Liu DJ; Fu XL; Tao LY; He RZ; Zhang JF; Hua R; Jiang SH; Sun YW; Liu W
Mol Oncol; 2021 Nov; 15(11):3076-3090. PubMed ID: 33932092
[TBL] [Abstract][Full Text] [Related]
10. Mutations of GNAQ, GNA11, SF3B1, EIF1AX, PLCB4 and CYSLTR in Uveal Melanoma in Chinese Patients.
Hou C; Xiao L; Ren X; Tang F; Guo B; Zeng W; Liang C; Yan N
Ophthalmic Res; 2020; 63(3):358-368. PubMed ID: 31614358
[TBL] [Abstract][Full Text] [Related]
11. Genetic testing in prolactinomas: a cohort study.
Boukerrouni A; Cuny T; Anjou T; Raingeard I; Ferrière A; Grunenwald S; Maïza JC; Marquant E; Sahakian N; Fodil-Cherif S; Salle L; Niccoli P; Randrianaivo H; Sonnet E; Chevalier N; Thuillier P; Vezzosi D; Reynaud R; Dufour H; Brue T; Tabarin A; Delemer B; Kerlan V; Castinetti F; Barlier A; Romanet P
Eur J Endocrinol; 2023 Dec; 189(6):567-574. PubMed ID: 37956455
[TBL] [Abstract][Full Text] [Related]
12. U2AF65-Dependent SF3B1 Function in SMN Alternative Splicing.
Choi N; Liu Y; Oh J; Ha J; Zheng X; Shen H
Cells; 2020 Dec; 9(12):. PubMed ID: 33317029
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Splicing Factor 3b Subunit 1 (SF3B1) Reduced Cell Proliferation, Induced Apoptosis and Resulted in Cell Cycle Arrest by Regulating Homeobox A10 (HOXA10) Splicing in AGS and MKN28 Human Gastric Cancer Cells.
Zhang Y; Yuan Z; Jiang Y; Shen R; Gu M; Xu W; Gu X
Med Sci Monit; 2020 Jan; 26():e919460. PubMed ID: 31927557
[TBL] [Abstract][Full Text] [Related]
14. SF3B1 mutant myelodysplastic syndrome: Recent advances.
Pellagatti A; Boultwood J
Adv Biol Regul; 2021 Jan; 79():100776. PubMed ID: 33358369
[TBL] [Abstract][Full Text] [Related]
15. Splicing factor SF3B1K700E mutant dysregulates erythroid differentiation via aberrant alternative splicing of transcription factor TAL1.
Jin S; Su H; Tran NT; Song J; Lu SS; Li Y; Huang S; Abdel-Wahab O; Liu Y; Zhao X
PLoS One; 2017; 12(5):e0175523. PubMed ID: 28545085
[TBL] [Abstract][Full Text] [Related]
16. Mutant SF3B1 promotes malignancy in PDAC.
Simmler P; Ioannidi EI; Mengis T; Marquart KF; Asawa S; Van-Lehmann K; Kahles A; Thomas T; Schwerdel C; Aceto N; Rätsch G; Stoffel M; Schwank G
Elife; 2023 Oct; 12():. PubMed ID: 37823551
[TBL] [Abstract][Full Text] [Related]
17. SF3B1 mutations constitute a novel therapeutic target in breast cancer.
Maguire SL; Leonidou A; Wai P; Marchiò C; Ng CK; Sapino A; Salomon AV; Reis-Filho JS; Weigelt B; Natrajan RC
J Pathol; 2015 Mar; 235(4):571-80. PubMed ID: 25424858
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42.
Zhao B; Li Z; Qian R; Liu G; Fan M; Liang Z; Hu X; Wan Y
J Biochem; 2022 Jul; 172(2):117-126. PubMed ID: 35652295
[TBL] [Abstract][Full Text] [Related]
20. m
Cieśla M; Ngoc PCT; Muthukumar S; Todisco G; Madej M; Fritz H; Dimitriou M; Incarnato D; Hellström-Lindberg E; Bellodi C
Mol Cell; 2023 Apr; 83(7):1165-1179.e11. PubMed ID: 36944332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]